China NMPA Drug Inspection - Jiangxi Heshuo Pharmaceutical Co., Ltd. - Salt-based Psoralea corylifolia
China NMPA drug inspection for Jiangxi Heshuo Pharmaceutical Co., Ltd. published December 29, 2020. Drug: Salt-based Psoralea corylifolia. The Guizhou Provincial Drug Administration released its fourth Drug Quality Announcement of 2020, documenting quality fa
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Jiangxi Heshuo Pharmaceutical Co., Ltd. published December 29, 2020. Drug: Salt-based Psoralea corylifolia. The Guizhou Provincial Drug Administration released its fourth Drug Quality Announcement of 2020, documenting quality fa
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox